Coronavirus (COVID-19) Resource Center

During the COVID-19 emergency period declared by the Public Health Act, providers are required to make public the cash price for the diagnostic test for COVID-19 [Reference: CARES Act Sec. 3202]. The cash price shown is for all Aspirus entities (listed below) in all care settings where tests are performed.

COVID-19 Diagnostic Test

• Cash Price: $221.00*
• COVID-19 Diagnostic Antigen (Rapid) Test Cash Price: $100.00*
• COVID-19 and Influenza A and B Diagnostic Nucleic Acid Test Panel Cash Price: $429.00*
• COVID-19, Influenza A and B, and RSV Diagnostic Nucleic Acid Test Panel Cash Price: $429.00*
• COVID-19 Lab Specimen Collection Cash Price: $32.00*

COVID-19 Antibody Test

• Cash Price: $43.00*
• COVID-19 Lab Specimen Collection Cash Price: $32.00*

**There is federal legislation, commonly known as the CARES Act, that mandates most health insurance carriers to cover the cost of diagnostic testing for COVID-19. Federally funded program(s) are also available to help cover the cost of COVID-19 testing for patients without insurance. There are some exceptions to this coverage. These exceptions include patients with Self-Funded Health Insurance plans and patients being tested without symptoms.

Please note: It is always best practice to contact your insurance provider to verify the cost or coverage of services.

Aspirus entities:

Clinics

• One adult support person.*

Compassionate Care

• Visitation not restricted during end-of-life situations for non-COVID-19 patients, but may be managed at the discretion of the care team.

COVID-19 patients

• Limited exceptions will be considered for COVID-19 positive or suspected patients regarding support persons and/or visitors during end of life, pediatric, labor and delivery, and disability situations.
• Visitors must sign an acknowledgement of risk statement.
• All considerations and protective measures will be managed at the discretion of the care team.

Inpatient areas

• One adult support person.*

Inpatient/Outpatient Surgery or Procedure

• One adult support person.* 
• It is recommended to wait in vehicle or designated location.

Labor and Delivery

• One adult care partner/labor support person.
• A Doula may be considered.

Nursing Home/Assisted Living residents

• Support persons are not allowed, however family members with special circumstances are encouraged to call the location to discuss. 

Outpatient Treatment Centers - Dialysis/Oncology

• One adult support person.*

Pediatric Patients (18 years of age or younger)

• Two primary adult support persons per patient will be allowed in inpatient, surgical and clinic settings.
• Patient siblings are not allowed.

All approved visitors must wear a face mask at all times.

No visitors are permitted who exhibit signs of fever or respiratory symptoms, answer "yes" to any of the COVID-19 screening questions, or who are in quarantine or isolation per Public Health.

*A support person is one who is essential to patient health, care giving, and decision making.  No visitors are allowed unless special circumstances apply.

The hallmark symptoms of COVID-19 are: 

Fever or chills

Cough

Shortness of breath or difficulty breathing

Fatigue

Muscle or body aches

Headache

New loss of taste or smell

Sore throat

Congestion or runny nose

Nausea or vomiting

Diarrhea

People with COVID-19 have had a wide range of symptoms reported – ranging from mild symptoms to severe illness. Symptoms may appear 2-14 days after exposure to the virus. People with these symptoms may have COVID-19. The CDC website has a wealth of information related to signs and symptoms related to COVID-19.

Per the CDC, a potential exposure means being a household contact or having close contact within 6 feet of an individual with confirmed or suspected COVID-19 for 15 minutes or more. The timeframe for having contact with an individual includes the period of time of 48 hours before the individual became symptomatic.

Diagnostic: Diagnostic testing confirms active infection.

Antibody: Antibody testing detects susceptibility for and past infection of COVID-19. Aspirus providers can now order COVID-19 antibody tests. Testing will be performed daily, with results available within 24 hours of the sample arriving at the Aspirus Wausau Hospital Lab. Antibody testing can be performed at any Aspirus lab location and patients are not being referred to the alternative testing sites.

View Testing Comparison

Aspirus has been working hard to prepare, however COVID-19 impacts us locally, but we can all play a role in helping slow its spread. By doing these things our community can help slow the spread of the virus. We’re all in this together.

 

If you have already received your COVID-19 test results and need to provide documentation to your employer to return to work, DO NOT call the Aspirus COVID-19 Call Center. Our Call Center Staff cannot help you with the required documentation. Instead, the quickest way to get this documentation is to log on to your MyAspirus account from a computer. Find the "print icon" on the right side of the screen and print your results to a paper printer or an electronic PDF printer. Please note that this is not available on a cell phone or tablet. Screenshots do not show your name and date of birth and often are not accepted by your employer and/or school.   
 
If you do not have a computer with a printer you will need to obtain a HIPAA Authorization form complete it and email it to aspirushealthinformation@aspirus.org to have health information share your results. This can take 2-3 days from the date that your HIPAA authorization has been received.